Application no. and date | 17180720.9 (espacenet) (Federated) (European Patent Register), 20100712 | Patent/reg. no. and date | DK/EP 3252070, 20191002 | Publication date | 20171206 | Priority no. and date | US 502181, 20090713 | EP pub. no. and date |
EP 3252070 20171206 | Effective date | | Applicant/owner | ALLERGAN, INC., 2525 Dupont Drive
Irvine CA 92612, US | Applicant ref. no. | P70772DK01 | Inventor | TON, Jennifer L., 3595 Sego Street
Irvine, CA 92606, US, PATEL, Hemant A., 12 Twilight Lane
Rancho Santa Margarita, CA 92688, US, BATES, Ronald C., 457 Shadow Oaks
Irivine, CA 92618, US, AHMAD, Wajdie M., 2103 Anacapa
Irvine, CA 92602, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 38/16 (2006.01) , C07K 14/33 (2006.01) , C12N 1/20 (2006.01) , C12P 21/02 (2006.01) | Title | FREMGANGSMÅDE OG SYSTEM TIL OPNÅELSE AF BOTULINUM-NEUROTOKSIN | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|